United States Cardiopulmonary Autotransfusion System Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Cardiopulmonary Autotransfusion System Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Cardiopulmonary Autotransfusion System Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Cardiopulmonary Autotransfusion System Overall Market Size
2.1 United States Cardiopulmonary Autotransfusion System Market Size: 2021 VS 2027
2.2 United States Cardiopulmonary Autotransfusion System Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Cardiopulmonary Autotransfusion System Sales: 2016-2027
3 Company Landscape
3.1 Top Cardiopulmonary Autotransfusion System Players in United States Market
3.2 Top United States Cardiopulmonary Autotransfusion System Companies Ranked by Revenue
3.3 United States Cardiopulmonary Autotransfusion System Revenue by Companies
3.4 United States Cardiopulmonary Autotransfusion System Sales by Companies
3.5 United States Cardiopulmonary Autotransfusion System Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cardiopulmonary Autotransfusion System Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Cardiopulmonary Autotransfusion System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cardiopulmonary Autotransfusion System Players in United States Market
3.8.1 List of Tier 1 Cardiopulmonary Autotransfusion System Companies in United States
3.8.2 List of Tier 2 and Tier 3 Cardiopulmonary Autotransfusion System Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Cardiopulmonary Autotransfusion System Market Size Markets, 2021 & 2027
4.1.2 Unwashed ATS
4.1.3 Washed ATS
4.2 By Type - United States Cardiopulmonary Autotransfusion System Revenue & Forecasts
4.2.1 By Type - United States Cardiopulmonary Autotransfusion System Revenue, 2016-2021
4.2.2 By Type - United States Cardiopulmonary Autotransfusion System Revenue, 2022-2027
4.2.3 By Type - United States Cardiopulmonary Autotransfusion System Revenue Market Share, 2016-2027
4.3 By Type - United States Cardiopulmonary Autotransfusion System Sales & Forecasts
4.3.1 By Type - United States Cardiopulmonary Autotransfusion System Sales, 2016-2021
4.3.2 By Type - United States Cardiopulmonary Autotransfusion System Sales, 2022-2027
4.3.3 By Type - United States Cardiopulmonary Autotransfusion System Sales Market Share, 2016-2027
4.4 By Type - United States Cardiopulmonary Autotransfusion System Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Cardiopulmonary Autotransfusion System Market Size, 2021 & 2027
5.1.2 Heart Surgery
5.1.3 Great Organ Transplant Surgery
5.1.4 Other Surgery
5.2 By Application - United States Cardiopulmonary Autotransfusion System Revenue & Forecasts
5.2.1 By Application - United States Cardiopulmonary Autotransfusion System Revenue, 2016-2021
5.2.2 By Application - United States Cardiopulmonary Autotransfusion System Revenue, 2022-2027
5.2.3 By Application - United States Cardiopulmonary Autotransfusion System Revenue Market Share, 2016-2027
5.3 By Application - United States Cardiopulmonary Autotransfusion System Sales & Forecasts
5.3.1 By Application - United States Cardiopulmonary Autotransfusion System Sales, 2016-2021
5.3.2 By Application - United States Cardiopulmonary Autotransfusion System Sales, 2022-2027
5.3.3 By Application - United States Cardiopulmonary Autotransfusion System Sales Market Share, 2016-2027
5.4 By Application - United States Cardiopulmonary Autotransfusion System Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Haemonetics
6.1.1 Haemonetics Corporation Information
6.1.2 Haemonetics Overview
6.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Description
6.1.5 Haemonetics Recent Developments
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Overview
6.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Description
6.2.5 Medtronic Recent Developments
6.3 LivaNova
6.3.1 LivaNova Corporation Information
6.3.2 LivaNova Overview
6.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Description
6.3.5 LivaNova Recent Developments
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Overview
6.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Description
6.4.5 Fresenius Kabi Recent Developments
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Overview
6.5.3 Terumo Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.5.4 Terumo Cardiopulmonary Autotransfusion System Product Description
6.5.5 Terumo Recent Developments
6.6 Wandong Health Sources
6.6.1 Wandong Health Sources Corporation Information
6.6.2 Wandong Health Sources Overview
6.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales and Revenue in United States Market (2016-2021)
6.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Description
6.6.5 Wandong Health Sources Recent Developments
7 United States Cardiopulmonary Autotransfusion System Production Capacity, Analysis
7.1 United States Cardiopulmonary Autotransfusion System Production Capacity, 2016-2027
7.2 Cardiopulmonary Autotransfusion System Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Cardiopulmonary Autotransfusion System Supply Chain Analysis
9.1 Cardiopulmonary Autotransfusion System Industry Value Chain
9.2 Cardiopulmonary Autotransfusion System Upstream Market
9.3 Cardiopulmonary Autotransfusion System Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cardiopulmonary Autotransfusion System Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Cardiopulmonary Autotransfusion System in United States Market
Table 2. Top Cardiopulmonary Autotransfusion System Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Cardiopulmonary Autotransfusion System Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Cardiopulmonary Autotransfusion System Revenue Share by Companies, 2016-2021
Table 5. United States Cardiopulmonary Autotransfusion System Sales by Companies, (Units), 2016-2021
Table 6. United States Cardiopulmonary Autotransfusion System Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cardiopulmonary Autotransfusion System Price (2016-2021) & (K US$/Unit)
Table 8. Manufacturers Cardiopulmonary Autotransfusion System Product Type
Table 9. List of Tier 1 Cardiopulmonary Autotransfusion System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cardiopulmonary Autotransfusion System Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Unwashed ATS
Table 12. Major Manufacturers of Washed ATS
Table 13. By Type - United States Cardiopulmonary Autotransfusion System Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Cardiopulmonary Autotransfusion System Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Cardiopulmonary Autotransfusion System Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Cardiopulmonary Autotransfusion System Sales (Units), 2016-2021
Table 17. By Type - United States Cardiopulmonary Autotransfusion System Sales (Units), 2022-2027
Table 18. By Application - United States Cardiopulmonary Autotransfusion System Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Cardiopulmonary Autotransfusion System Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Cardiopulmonary Autotransfusion System Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Cardiopulmonary Autotransfusion System Sales (Units), 2016-2021
Table 22. By Application - United States Cardiopulmonary Autotransfusion System Sales (Units), 2022-2027
Table 23. Haemonetics Corporation Information
Table 24. Haemonetics Description and Major Businesses
Table 25. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 26. Haemonetics Cardiopulmonary Autotransfusion System Product
Table 27. Haemonetics Recent Developments
Table 28. Medtronic Corporation Information
Table 29. Medtronic Description and Major Businesses
Table 30. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 31. Medtronic Cardiopulmonary Autotransfusion System Product
Table 32. Medtronic Recent Developments
Table 33. LivaNova Corporation Information
Table 34. LivaNova Description and Major Businesses
Table 35. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 36. LivaNova Cardiopulmonary Autotransfusion System Product
Table 37. LivaNova Recent Developments
Table 38. Fresenius Kabi Corporation Information
Table 39. Fresenius Kabi Description and Major Businesses
Table 40. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 41. Fresenius Kabi Cardiopulmonary Autotransfusion System Product
Table 42. Fresenius Kabi Recent Developments
Table 43. Terumo Corporation Information
Table 44. Terumo Description and Major Businesses
Table 45. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 46. Terumo Cardiopulmonary Autotransfusion System Product
Table 47. Terumo Recent Developments
Table 48. Wandong Health Sources Corporation Information
Table 49. Wandong Health Sources Description and Major Businesses
Table 50. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$, Mn) and Gross Margin (K US$/Unit) (2016-2021)
Table 51. Wandong Health Sources Cardiopulmonary Autotransfusion System Product
Table 52. Wandong Health Sources Recent Developments
Table 53. Cardiopulmonary Autotransfusion System Production Capacity (Units) of Key Manufacturers in United States Market, 2019-2021 (Units)
Table 54. United States Cardiopulmonary Autotransfusion System Capacity Market Share of Key Manufacturers, 2019-2021
Table 55. Cardiopulmonary Autotransfusion System Market Opportunities & Trends in United States Market
Table 56. Cardiopulmonary Autotransfusion System Market Drivers in United States Market
Table 57. Cardiopulmonary Autotransfusion System Market Restraints in United States Market
Table 58. Cardiopulmonary Autotransfusion System Raw Materials
Table 59. Cardiopulmonary Autotransfusion System Raw Materials Suppliers in United States Market
Table 60. Typical Cardiopulmonary Autotransfusion System Downstream
Table 61. Cardiopulmonary Autotransfusion System Downstream Clients in United States Market
Table 62. Cardiopulmonary Autotransfusion System Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Cardiopulmonary Autotransfusion System Product Picture
Figure 2. Cardiopulmonary Autotransfusion System Segment by Type
Figure 3. Cardiopulmonary Autotransfusion System Segment by Application
Figure 4. United States Cardiopulmonary Autotransfusion System Market Overview: 2020
Figure 5. United States Cardiopulmonary Autotransfusion System Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Cardiopulmonary Autotransfusion System Revenue, 2016-2027 (US$, Mn)
Figure 7. Cardiopulmonary Autotransfusion System Sales in United States Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Cardiopulmonary Autotransfusion System Revenue in 2020
Figure 9. Unwashed ATS Product Picture
Figure 10. Washed ATS Product Picture
Figure 11. By Type - United States Cardiopulmonary Autotransfusion System Sales Market Share, 2016-2027
Figure 12. By Type - United States Cardiopulmonary Autotransfusion System Revenue Market Share, 2016-2027
Figure 13. By Type - United States Cardiopulmonary Autotransfusion System Price (K US$/Unit), 2016-2027
Figure 14. Heart Surgery
Figure 15. Great Organ Transplant Surgery
Figure 16. Other Surgery
Figure 17. By Application - United States Cardiopulmonary Autotransfusion System Sales Market Share, 2016-2027
Figure 18. By Application - United States Cardiopulmonary Autotransfusion System Revenue Market Share, 2016-2027
Figure 19. By Application - United States Cardiopulmonary Autotransfusion System Price (K US$/Unit), 2016-2027
Figure 20. Haemonetics Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Medtronic Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. LivaNova Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Fresenius Kabi Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Terumo Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Wandong Health Sources Cardiopulmonary Autotransfusion System Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Cardiopulmonary Autotransfusion System Production Capacity (Units), 2016-2027
Figure 27. Cardiopulmonary Autotransfusion System Industry Value Chain
Figure 28. Marketing Channels